DE60109279D1 - Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung - Google Patents

Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung

Info

Publication number
DE60109279D1
DE60109279D1 DE60109279T DE60109279T DE60109279D1 DE 60109279 D1 DE60109279 D1 DE 60109279D1 DE 60109279 T DE60109279 T DE 60109279T DE 60109279 T DE60109279 T DE 60109279T DE 60109279 D1 DE60109279 D1 DE 60109279D1
Authority
DE
Germany
Prior art keywords
oligosaccharides
preparation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60109279T
Other languages
English (en)
Other versions
DE60109279T2 (de
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60109279D1 publication Critical patent/DE60109279D1/de
Publication of DE60109279T2 publication Critical patent/DE60109279T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
DE60109279T 2000-03-28 2001-03-26 Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung Expired - Fee Related DE60109279T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003910A FR2807043B1 (fr) 2000-03-28 2000-03-28 Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
FR0003910 2000-03-28
PCT/FR2001/000903 WO2001072762A1 (fr) 2000-03-28 2001-03-26 Compositions pharmaceutiques contenant des oligosaccharides et leur preparation

Publications (2)

Publication Number Publication Date
DE60109279D1 true DE60109279D1 (de) 2005-04-14
DE60109279T2 DE60109279T2 (de) 2006-04-13

Family

ID=8848572

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60109279T Expired - Fee Related DE60109279T2 (de) 2000-03-28 2001-03-26 Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung

Country Status (27)

Country Link
EP (1) EP1272499B1 (de)
JP (1) JP2003529570A (de)
KR (1) KR20030001394A (de)
CN (1) CN1183149C (de)
AR (1) AR034251A1 (de)
AT (1) ATE290543T1 (de)
AU (1) AU782713B2 (de)
BR (1) BR0109617A (de)
CA (1) CA2403906A1 (de)
DE (1) DE60109279T2 (de)
EA (1) EA004768B1 (de)
EE (1) EE200200551A (de)
ES (1) ES2236206T3 (de)
FR (1) FR2807043B1 (de)
HK (1) HK1056564A1 (de)
HU (1) HUP0300330A3 (de)
IL (1) IL151832A0 (de)
ME (1) MEP88408A (de)
MX (1) MXPA02009455A (de)
NO (1) NO20024590D0 (de)
NZ (1) NZ521558A (de)
PL (1) PL204419B1 (de)
PT (1) PT1272499E (de)
SK (1) SK286745B6 (de)
WO (1) WO2001072762A1 (de)
YU (1) YU72802A (de)
ZA (1) ZA200207707B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (ja) * 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
WO2007026485A1 (ja) 2005-08-30 2007-03-08 Inter-University Research Institute Corporation National Institutes Of Natural Sciences ユニバーサル塩基
EP3418287A1 (de) * 2017-06-21 2018-12-26 Universität für Bodenkultur Wien Chemische freisetzung von asparagine-verbundenen glykanen
CN115317507A (zh) * 2022-09-19 2022-11-11 中国科学院海洋研究所 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
IL151832A0 (en) 2003-04-10
YU72802A (sh) 2006-01-16
ATE290543T1 (de) 2005-03-15
AR034251A1 (es) 2004-02-18
PT1272499E (pt) 2005-06-30
PL357301A1 (en) 2004-07-26
EP1272499A1 (de) 2003-01-08
EE200200551A (et) 2004-04-15
PL204419B1 (pl) 2010-01-29
MXPA02009455A (es) 2003-02-12
HK1056564A1 (en) 2004-02-20
CA2403906A1 (fr) 2001-10-04
CN1183149C (zh) 2005-01-05
JP2003529570A (ja) 2003-10-07
NO20024590L (no) 2002-09-25
EA004768B1 (ru) 2004-08-26
MEP88408A (en) 2011-12-20
DE60109279T2 (de) 2006-04-13
AU4663901A (en) 2001-10-08
AU782713B2 (en) 2005-08-25
CN1426419A (zh) 2003-06-25
HUP0300330A2 (hu) 2003-06-28
EA200201024A1 (ru) 2003-02-27
FR2807043A1 (fr) 2001-10-05
SK13932002A3 (sk) 2003-06-03
EP1272499B1 (de) 2005-03-09
WO2001072762A1 (fr) 2001-10-04
BR0109617A (pt) 2003-02-04
FR2807043B1 (fr) 2002-11-22
SK286745B6 (sk) 2009-04-06
ES2236206T3 (es) 2005-07-16
KR20030001394A (ko) 2003-01-06
NO20024590D0 (no) 2002-09-25
HUP0300330A3 (en) 2003-09-29
NZ521558A (en) 2005-10-28
ZA200207707B (en) 2003-12-24

Similar Documents

Publication Publication Date Title
DE60142890D1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE60138872D1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE60318188D1 (de) Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
ATE280583T1 (de) Stabilisierte pharmazeutische zusammentsetzung in lyophilisierter form
DE69916288D1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
CY2013032I1 (el) Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
ATE250593T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE60029115D1 (de) Antigen enthaltende pharmazeutische zusammensetzung
ATE298571T1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
DE60038304D1 (de) Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
ATE468324T1 (de) Pharmazeutische zusammensetzung
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE50011656D1 (de) Benzodiazepin-derivate, deren herstellung und anwendung
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
DE59915033D1 (de) Pharmazeutische Zubereitung
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung
DE60109279D1 (de) Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung
DE60129238D1 (de) Pharmazeutische zusammensetzung
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
FI20002768A (fi) Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
DE60126046D1 (de) Bizyklische Amino-Pyrazon Derivate, deren Herstellung und pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8339 Ceased/non-payment of the annual fee